Skip to main content
Premium Trial:

Request an Annual Quote

Epoch Biosciences Posts Surge in Q4 Revenue, Narrowed Loss

NEW YORK, Feb. 12 - Epoch Biosciences on Tuesday reported a surge in total revenues for the fourth quarter 2001 and a narrowed loss as strong sales outpaced a slight jump in operating costs.


For the period ended Dec. 31, the genomics tool company reported total revenue of $2.2 million compared with $945,000 one year ago, driven by a jump in license fees and royalties to $722,000 from $30,000 year over year.

Product sales also helped nudge the top line as the company sold $946,000 of its Eclipse PCR tools and its DNAnchor microarrays compared with $665,000 the firm earned in sales in the same period one year ago.

Revenue from contract research also grew in the quarter, to $585,000 from $250,000 one year ago, thanks in part to a research collaboration and part of a SBIR grant awarded to the company in 2001.


Leading a modest increase in total operating expenses, R&D spending inched up to $1.4 million from $1.1 million in the year-ago period, though net loss still managed to fall to $934,000, or $.04 per share, from $1.4 million, or $.05 per share, recorded in the same period last year.


Shares in the Bothell, Wash.-based were off $.01, or about half a percent, to $1.94 in mid-morning Nasdaq trade.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.